Factors such as government regulations and initiatives, growing popularity of patient engagement solutions among the aging population, significant investments by stakeholders, and rising number of collaborations and partnerships between vendors and end users are some of the factors driving the growth of the patient engagement solutions market. Patient engagement solutions are gaining popularity across the globe; the use of health information technologies and online resources in healthcare boosts care quality by improving care access, efficiency, chronic disease management, and patient &family involvement. Patient engagement solutions offer various features that enhance patient-provider communication and involve patients in their own care. The benefits of patient engagement solutions have fueled their adoption globally. However, reluctance among providers towards the adoption of patient engagement solutions, requirement of infrastructural investments, and lack of interoperability are some of the factors expected to restrain the growth of this market. On the other hand, emerging economies in the Asian region, growing medical tourism, and growing use of cloud-based models offer growth opportunities for players in the market.

The software component segment is estimated to account for the largest share of the global patient engagement solutions market in 2015.Software is a non-tangible component used as an application to run a system or to perform primary tasks, which include maintaining patient records, analyzing databases, and performing administrative tasks in any healthcare organization or hospital.

Geographically, North America is expected to account for the largest share of the global patient engagement solutions market in 2015, followed by Europe, Asia, and the Rest of the World (RoW).The large share of North American is attributed to the federal mandates in the U.S., rising number of ACOs as end users for patient engagement solutions, rising aging population in the U.S, Canada’s efforts to enhance healthcare delivery, and digital health measures in Canada.

Major players in the market are focusing on various strategies, such as product deployments; agreements, alliances, collaborations, and partnerships; new product launches (including product enhancements); acquisitions; expansions; and other strategies (divestment, funding, and product integration),to establish a strong foothold in the global patient engagement solutions market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

•    Market Penetration: Comprehensive information on the solutions offered by top players in the patient engagement solutions market. The report analyzes the patient engagement solutions market, by component, delivery mode, end user, application, and therapeutic area

•    Product Development/Innovation: Detailed insights on research and development activities and new product launches in the patient engagement solutions market

•    Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the patient engagement solutions market across regions

•    Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the patient engagement solutions market

•    Competitive Assessment: In-depth assessment of strategies, products, and distribution networks of the leading players in the patient engagement solutions market

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.3 Key Data From Secondary Sources
2.3.1 Primary Research
2.3.2 Key Industry Insights
2.4 Key Data From Primary Sources
2.5 Key Insights From Primary Sources
2.6 Market Size Estimation Methodology
2.7 Market Forecast Methodology
2.8 Market Data Validation and Triangulation
2.9 Assumptions

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Global Patient Engagement Solutions Market
4.2 Geographic Analysis: Market, By End User
4.3 Market, By Component (2015 vs 2020)

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Government Regulations and Initiatives
5.3.1.2 Growing Popularity of Patient Engagement Solutions Among the Aging Population
5.3.1.3 Significant Investments By Stakeholders
5.3.1.4 Rising Number of Collaborations and Partnerships Between Vendors and End Users
5.3.1.5 Increasing Utilization of Mobile Health (Mhealth)
5.3.2 Restraints
5.3.2.1 Reluctance Among Providers Towards the Adoption of Patient Engagement Solutions
5.3.2.2 Requirement of Infrastructural Investments
5.3.2.3 Protection of Patient Information
5.3.2.4 Lack of Interoperability
5.3.3 Opportunities
5.3.3.1 Emerging Economies in the Asian Region
5.3.3.2 Growing Medical Tourism
5.3.3.3 Wearable Health Technology
5.3.3.4 Cloud-Based Models
5.3.4 Challenges
5.3.4.1 High Cost of Deployment
5.3.4.2 Lack of Health Literacy
5.3.4.3 Dearth of Skilled It Professionals in the Healthcare Industry

6 Adoption Assessment of Patient Engagement Solutions Market in the U.S.
6.1 Introduction
6.1.1 U.S.: Patient Engagement Solutions Adoption Assessment, By Vendor
6.1.1.1 Medical Information Technology, Inc.
6.1.1.2 Eclinicalworks
6.1.1.3 Athenahealth, Inc.
6.1.1.4 Allscripts Healthcare Solutions, Inc.
6.1.2 U.S.: Patient Engagement Solutions Adoption Assessment, By Solution

7 Patient Engagement Solutions Market, By Component
7.1 Introduction
7.2 Software
7.2.1 Standalone Software
7.2.2 Integrated Software
7.3 Services
7.4 Hardware

8 Patient Engagement Solutions Market, By Delivery Mode
8.1 Introduction
8.2 Web-Based
8.3 On-Premise
8.4 Cloud-Based

9 Patient Engagement Solutions Market, By End User
9.1 Introduction
9.2 Providers
9.3 Payers
9.4 Individual Users
9.5 Others

10 Patient Engagement Solutions Market, By Application
10.1 Introduction
10.2 Health Management
10.3 Social and Behavioral Management
10.4 Home Health Management
10.5 Financial Health Management

11 Patient Engagement Solutions Market, By Therapeutic Area
11.1 Introduction
11.2 Chronic Diseases
11.2.1 Diabetes
11.2.2 Cardiovascular Disease
11.2.3 Obesity
11.2.4 Other Chronic Diseases
11.3 Women’s Health
11.4 Fitness
11.5 Other Therapeutic Areas

12 Patient Engagement Solutions Market, By Region
12.1 Introduction
12.2 North America
12.2.1 U.S.
12.2.1.1 Legislations and Initiatives to Promote ‘Patient-Centeredness’ in Healthcare
12.2.1.2 Increasing Number of Accountable Care Organizations
12.2.1.3 Need to Curb Healthcare Costs
12.2.1.4 Focus on Shared Decision-Making
12.2.1.5 Hospital Readmissions Reduction Program (HRRP)
12.2.1.6 Pharmaceuticals Industry Propelling the Patient Engagement Solutions Market in U.S.
12.2.1.7 Increase in Insurance Coverage
12.2.1.8 Increasing Investments in Patient Engagement
12.2.1.9 Impetus on Fulfilling the Requirements of ‘Meaningful Use’ Through Patient Engagement
12.2.1.10 Thrust Given to Api in Stage 3 Meaningful Use Rules
12.2.2 Canada
12.2.2.1 Digital Health Measures
12.2.2.2 Prevalence of Chronic Diseases
12.2.2.3 Patient Engagement, A Prerequisite for Accreditation
12.3 Europe
12.3.1 Rising Healthcare Costs and Aging Population
12.3.2 Growth of the Hcit Market and Consolidation of Healthcare Providers in Europe
12.3.3 Growing Focus on Ehealth
12.3.4 Germany
12.3.4.1 Rising Demand for Advanced Healthcare Solutions and Efficient Healthcare Delivery in Germany
12.3.5 U.K.
12.3.5.1 Role of the Nhs
12.3.6 France
12.3.6.1 Implementation of the Dossier Médical Personnel (DMP) in France
12.3.7 Rest of Europe (RoE)
12.4 Asia
12.4.1 Growth in Medical Tourism
12.4.2 Need to Control Rising Healthcare Expenditure in India
12.4.3 Japan’s Ict Policies
12.4.4 ‘One Singaporean, One Health Record’ Program
12.4.5 Growth of China’s Digital Healthcare
12.4.6 “Digital India” Campaign and Digital Healthcare Scenario in India
12.5 Rest of the World
12.5.1 Prevalence of Chronic Diseases
12.5.2 Increased Healthcare Spending in the Middle East
12.5.3 Growth of the Hcit Market in Latin America
12.5.4 Product Deployments and Hcit Programs in Australia

13 Competitive Landscape
13.1 Overview
13.2 Competitive Situation and Trends
13.2.1 Product Deployments
13.2.2 Agreements, Partnerships, and Collaborations
13.2.3 New Product Launches and Product Enhancements
13.2.4 Expansions
13.2.5 Acquisitions
13.2.6 Other Strategies

14 Company Profiles
14.1 Introduction
14.2 Mckesson Corporation
14.2.1 Business Overview
14.2.2 Products Offered
14.2.3 Recent Developments
14.2.4 MnM View
14.3 Allscripts Healthcare Solutions, Inc.
14.3.1 Business Overview
14.3.2 Products & Services Offered
14.3.3 Recent Developments
14.3.4 MnM View
14.4 Phytel, Inc. (Acquired By IBM Corporation)
14.4.1 Business Overview
14.4.2 Products Offered
14.4.3 Recent Developments
14.4.4 MnM View
14.5 Athenahealth, Inc.
14.5.1 Business Overview
14.5.2 Products & Services Offered
14.5.3 Recent Developments
14.5.4 MnM View
14.6 Cerner Corporation
14.6.1 Business Overview
14.6.2 Products Offered
14.6.3 Recent Developments
14.6.4 MnM View
14.7 Orion Health Ltd.
14.7.1 Business Overview
14.7.2 Products Offered
14.7.3 Recent Developments
14.8 Getwellnetwork, Inc.
14.8.1 Business Overview
14.8.2 Products Offered
14.8.3 Recent Developments
14.9 Lincor Solutions Ltd.
14.9.1 Business Overview
14.9.2 Products Offered
14.9.3 Recent Developments
14.10 Yourcareuniverse, Inc.
14.10.1 Business Overview
14.10.2 Products Offered
14.10.3 Recent Developments
14.11 Welvu, Inc.
14.11.1 Business Overview
14.11.2 Products Offered
14.11.3 Recent Developments
14.12 Get Real Health
14.12.1 Business Overview
14.12.2 Products and Services Offered
14.12.3 Recent Developments
14.13 Oneview Healthcare
14.13.1 Business Overview
14.13.2 Products Offered
14.13.3 Recent Developments
14.14 Patientpoint
14.14.1 Business Overview
14.14.2 Recent Developments
14.15 Medecision Inc.
14.15.1 Business Overview
14.15.2 Products Offered
14.15.3 Recent Developments
14.16 EMMI Solutions, LLC
14.16.1 Business Overview
14.16.2 Products & Services Offered
14.16.3 Recent Developments

15 Appendix
15.1 Discussion Guide
15.2 Other Developments, By Company (2013-2016)
15.2.1 Mckesson Corporation
15.2.2 Allscripts Healthcare Solutions, Inc.
15.2.3 Phytel (Acquired By IBM)
15.2.4 Athenahealth, Inc.
15.2.5 Orion Health Ltd.
15.2.6 Cerner Corporation
15.2.7 Getwellnetwork, Inc.
15.2.8 Lincor Solutions Ltd.
15.2.9 Yourcareuniverse, Inc.
15.2.10 Get Real Health
15.2.11 Oneview Healthcare
15.2.12 Patientpoint
15.2.13 Medecision Inc.
15.2.14 EMMI Solutions, LLC
15.3 Introducing RT: Real-Time Market Intelligence
15.4 Available Customizations
15.5 Related Reports

List of Tables

Table1 Federal Mandates are Propelling the Growth of Global Patient Engagement Solutions Market
Table 2 Indicative List of Collaborations Between Organizations From 2013-2015
Table 3 Reluctance Among Providers for the Adoption of Patient Engagement Solutions Acts as A Key Restraint
Table 4 Cloud-Based Patient Engagement Solutions Offer A Huge Potential for the Market Growth
Table 5 Lack of Health Literacy is A Major Challenge for the Market
Table 6 Top Three Patient Engagement Solutions Deployed (Jan 2013-Jan 2016)
Table 7 Global Patient Engagement Solutions Market Size, By Component, 2013–2020 (USD Million)
Table 8 Patient Engagement Software Market Size, By Region, 2013–2020 (USD Million)
Table 9 Patient Engagement Software Market Size, By Type, 2013–2020 (USD Million)
Table10 Patient Engagement Standalone Software Market Size, By Region, 2013–2020 (USD Million)
Table11 Patient Engagement Integrated Software Market Size, By Region, 2013–2020 (USD Million)
Table12 Patient Engagement Services Market Size, By Region, 2013–2020 (USD Million)
Table13 Patient Engagement Hardware Market Size, By Region, 2013–2020 (USD Million)
Table14 Global Patient Engagement Solutions Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table15 Web-Based Patient Engagement Solutions Market Size, By Region, 2013–2020 (USD Million)
Table16 On-Premise Market Size, By Region, 2013–2020 (USD Million)
Table17 Cloud-Based Market Size, By Region, 2013–2020 (USD Million)
Table18 Global Patient Engagement Solutions Market Size, By End User, 2013–2020 (USD Million)
Table19 Patient Engagement Solutions Market Size for Healthcare Providers, By Region, 2013–2020 (USD Million)
Table 20 Patient Engagement Solutions Market Size for Healthcare Payers, By Region, 2013–2020 (USD Million)
Table 21 Patient Engagement Solutions Market Size for Individual Users, By Region, 2013–2020 (USD Million)
Table 22 Patient Engagement Solutions Market Size for Others, By Region, 2013–2020 (USD Million)
Table 23 Global Market Size, By Application, 2013–2020 (USD Million)
Table 24 Patient Engagement Solutions Market Size for Health Management, By Region, 2013–2020 (USD Million)
Table 25 Market Size for Social and Behavioral Management, By Region, 2013–2020 (USD Million)
Table 26 Market Size for Home Health Management, By Region, 2013–2020 (USD Million)
Table 27 Market Size for Financial Health Management, By Region, 2013–2020 (USD Million)
Table 28 Global Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 29 Market Size for Chronic Diseases, By Region, 2013–2020 (USD Million)
Table 30 Market Size for Chronic Diseases, By Type, 2013–2020 (USD Million)
Table 31 Market Size for Diabetes, By Region, 2013–2020 (USD Million)
Table 32 Market Size for Cardiovascular Disease, By Region, 2013–2020 (USD Million)
Table 33 Market Size for Obesity, By Region, 2013–2020 (USD Million)
Table 34 Market Size for Other Chronic Diseases, By Region, 2013–2020 (USD Million)
Table 35 Market Size for Women’s Health, By Region, 2013–2020 (USD Million)
Table 36 Market Size for Fitness, By Region, 2013–2020 (USD Million)
Table 37 Market Size for Other Therapeutic Areas, By Region, 2013–2020 (USD Million)
Table 38 Market Size, By Region, 2013–2020 (USD Million)
Table 39 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 40 North America: Market Size, By Component, 2013–2020 (USD Million)
Table 41 North America: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 42 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 43 North America: Market Size, By Application, 2013–2020 (USD Million)
Table 44 North America: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 45 U.S.: Market Size, By Component, 2013–2020 (USD Million)
Table 46 U.S.: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 47 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 48 U.S.: Market Size, By Application, 2013–2020 (USD Million)
Table 49 U.S.: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 50 Canada: Market Size, By Component, 2013–2020 (USD Million)
Table 51 Canada: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 52 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 53 Canada: Market Size, By Application, 2013–2020 (USD Million)
Table 54 Canada: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 55 Indicative List of Ehealth Projects Undertaken By the European Union
Table 56 Europe: Market Size, By Region, 2013–2020 (USD Million)
Table 57 Europe: Market Size, By Component, 2013–2020 (USD Million)
Table 58 Europe: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 59 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 60 Europe: Market Size, By Application, 2013–2020 (USD Million)
Table 61 Europe: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 62 Germany: Market Size, By Component, 2013–2020 (USD Million)
Table 63 Germany: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 64 Germany: Market Size, By End User, 2013–2020 (USD Million)
Table 65 Germany: Market Size, By Application, 2013–2020 (USD Million)
Table 66 Germany: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 67 U.K.: Market Size, By Component, 2013–2020 (USD Million)
Table 68 U.K.: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 69 U.K.: Market Size, By End User, 2013–2020 (USD Million)
Table 70 U.K.: Market Size, By Application, 2013–2020 (USD Million)
Table 71 U.K.: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 72 France: Market Size, By Component, 2013–2020 (USD Million)
Table 73 France: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 74 France: Market Size, By End User, 2013–2020 (USD Million)
Table 75 France: Market Size, By Application, 2013–2020 (USD Million)
Table 76 France: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 77 RoE: Market Size, By Component, 2013–2020 (USD Million)
Table 78 RoE: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 79 RoE: Market Size, By End User, 2013–2020 (USD Million)
Table 80 RoE: Market Size, By Application, 2013–2020 (USD Million)
Table 81 RoE: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 82 Asia: Market Size, By Component, 2013–2020 (USD Million)
Table 83 Asia: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 84 Asia: Market Size, By End User, 2013–2020 (USD Million)
Table 85 Asia: Market Size, By Application, 2013–2020 (USD Million)
Table 86 Asia: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 87 RoW: Market Size, By Component, 2013–2020 (USD Million)
Table 88 RoW: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 89 RoW: Market Size, By End User, 2013–2020 (USD Million)
Table 90 RoW: Market Size, By Application 2013–2020 (USD Million)
Table 91 RoW: Market Size, By Therapeutic Area, 2013–2020 (USD Million)
Table 92 Product Deployments, 2013–2016
Table 93 Agreements, Partnerships, and Collaborations 2013–2016
Table 94 New Product Launches and Product Enhancements, 2013–2016
Table 95 Other Developments, 2013–2016

List of Figures

Figure1 Global Patient Engagement Market: Research Methodology Steps
Figure 2 Sampling Frame: Primary Research
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Research Design
Figure 7 Data Triangulation Methodology
Figure 8 North America Dominates the Global Market in 2015
Figure 9 Providers Segment to Grow at the Highest CAGR From 2015 to 2020
Figure10 Europe to Witness the Highest Growth Rate During the Forecast Period
Figure11 Patient Engagement Solutions to Register Double Digit Growth in the Forecast Period
Figure12 North America Dominates the Market in 2015
Figure13 European Region to Witness the Highest Growth Rate During the Forecast Period
Figure14 Software Segment Commands the Largest Share of the Market in 2015
Figure15 Global Patient Engagement Solutiona Market
Figure16 Drivers, Restraints, Opportunities, & Challenges
Figure17 Leading Vendors Providing Patient Engagement Solutions to Healthcare Providers (Jan 2013–Jan 2016)
Figure18 Patient Engagement Solutions Adopted in U.S. (Jan 2013 to Jan 2016)
Figure19 Patient Engagement Software Market, By Type
Figure 20 Healthcare Providers to Account for the Largest Share of Market in 2015
Figure 21 Europe to Grow at the Highest CAGR in the Patient Engagement Solutions Market in 2015
Figure 22 U.S. Commands the Largest Share in the Patient Engagement Solutions Market in North America
Figure 23 Germany Commands the Largest Share of the Patient Engagement Solutions Market in Europe
Figure 24 Asia Commands for the Third Largest Market Share of the Global Patient Engagement Solutions Market
Figure 25 Providers in End-Users Segment Dominates RoW Patient Engagement Solutions Market
Figure 26 Top 5 Strategies Adopted By Players During 2013-2016
Figure 27 Battle for Market Share: Agreements, Collaborations, and Partnerships Was the Key Strategy Adopted By Market Players (2013–2016)
Figure 28 Geographic Revenue Mix of Market Players
Figure 29 Mckesson Corporation: Company Snapshot
Figure 30 Allscripts Healthcare Solutions, Inc.: Company Snapshot
Figure 31 IBM Corporation: Company Snapshot
Figure 32 Athenahealth, Inc.: Company Snapshot
Figure 33 Cerner Corporation: Company Snapshot
Figure 34 Orion Health Ltd.: Company Snapshot